Private Health Management (PHM), a leader in precision medicine and personalized care for serious and complex medical ...
Indian philanthropy, CSR initiatives, government funding, and nonprofits hold the power to alleviate the economic burden of ...
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...
In this video, Xiuning Le, MD, PhD, discusses how the definition of EGFR-mutated lung cancer has expanded in recent years.
Russia's announcement of a personalised mRNA cancer vaccine has generated excitement, but experts urge caution. While mRNA ...
Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...
On World Cancer Day, Dr. Sharat Chandra Goteti, one of the top medical oncologists associated with American Oncology ...
AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...
With one in every nine Indians at risk of developing cancer and a 12.8 per cent projected increase in annual cases by 2025, these daycare cancer centers will play a crucial role in reducing the burden ...
GlobalData on MSN2d
MAIA’s lung cancer therapy 99% more likely to improve OS over chemo aloneA treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC) options could extend overall survival (OS) to 16.9 months according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback